<metapackage xmlns:os="http://opensuse.org/Standards/One_Click_Install" xmlns="http://opensuse.org/Standards/One_Click_Install">
  <group>
    <repositories>
      <repository recommended="true">
        <name>devel:languages:R:autoCRAN</name>
        <summary>Large parts of CRAN (cran.r-project.org) mirrored to OBS in a fully automatic way.</summary>
        <description>This repo contains a large part of CRAN automatically converted to rpm packages.
*ALL* packages in the repo are created and kept uptodate(!) in a fully automatic way using the R package CRAN2OBS (gitlab.com/dsteuer/CRAN2OBS).
At the moment CRAN2OBS is still subject to many changes, but it already works well enough to bring about 15k packages from CRAN to Suse.
If you find packages not working, please contact me. Do not push packages here by hand after manually altering anything in a spec file, please. If you find an important package still missing, send a note, please. May be it is easy to add fitting rules to the scripts. 

Attention: there are Prefer: lines in the project config. Should be rechecked from time to time.</description>
        <url>https://download.opensuse.org/repositories/devel:/languages:/R:/autoCRAN/15.5/</url>
      </repository>
      <repository recommended="true">
        <name>deleted</name>
        <summary>INTERNAL PROJECT</summary>
        <description>don't delete this project, it's used for internal purposes</description>
        <url>https://download.opensuse.org/repositories/deleted/deleted/</url>
      </repository>
      <repository recommended="true">
        <name>openSUSE:Leap:15.5</name>
        <summary></summary>
        <description>openSUSE Leap borrows packages from SLE. The content of the build media is almost the same as Leap:15.2, but the development is drastic different. It includes the binaries (instead of the sources) directly from SLE. https://lists.opensuse.org/opensuse-factory/2020-04/msg00165.html</description>
        <url>https://download.opensuse.org/repositories/openSUSE:/Leap:/15.5/standard/</url>
      </repository>
      <repository recommended="true">
        <name>openSUSE:Backports:SLE-15-SP5</name>
        <summary>Backports project for SLE-15-SP5</summary>
        <description>Backports project for SLE-15-SP5</description>
        <url>https://download.opensuse.org/repositories/openSUSE:/Backports:/SLE-15-SP5/standard/</url>
      </repository>
      <repository recommended="true">
        <name>SUSE:SLE-15-SP5:GA</name>
        <summary></summary>
        <description></description>
        <url>https://download.opensuse.org/repositories/SUSE:/SLE-15-SP5:/GA/pool/</url>
      </repository>
      <repository recommended="true">
        <name>SUSE:SLE-15-SP4:Update</name>
        <summary>SLE 15 SP4</summary>
        <description>SLE 15 SP4</description>
        <url>https://download.opensuse.org/distribution/leap/15.5/repo/oss/</url>
      </repository>
      <repository recommended="true">
        <name>SUSE:SLE-15-SP4:GA</name>
        <summary></summary>
        <description></description>
        <url>https://download.opensuse.org/repositories/SUSE:/SLE-15-SP4:/GA/pool/</url>
      </repository>
      <repository recommended="true">
        <name>SUSE:SLE-15-SP3:Update</name>
        <summary>SLE 15 SP3</summary>
        <description>SLE 15 SP3</description>
        <url>https://download.opensuse.org/distribution/leap/15.5/repo/oss/</url>
      </repository>
      <repository recommended="true">
        <name>SUSE:SLE-15-SP3:GA</name>
        <summary></summary>
        <description></description>
        <url>https://download.opensuse.org/repositories/SUSE:/SLE-15-SP3:/GA/pool/</url>
      </repository>
      <repository recommended="true">
        <name>SUSE:SLE-15-SP2:Update</name>
        <summary>SLE 15 SP2</summary>
        <description>SLE 15 SP2</description>
        <url>https://download.opensuse.org/distribution/leap/15.5/repo/oss/</url>
      </repository>
      <repository recommended="true">
        <name>SUSE:SLE-15-SP2:GA</name>
        <summary>SLE 15 SP2</summary>
        <description>SLE 15 SP2</description>
        <url>https://download.opensuse.org/repositories/SUSE:/SLE-15-SP2:/GA/pool/</url>
      </repository>
      <repository recommended="true">
        <name>SUSE:SLE-15-SP1:Update</name>
        <summary>SLE 15 SP1</summary>
        <description>SLE 15 SP1</description>
        <url>https://download.opensuse.org/distribution/leap/15.5/repo/oss/</url>
      </repository>
      <repository recommended="true">
        <name>SUSE:SLE-15-SP1:GA</name>
        <summary>SLE 15 SP1</summary>
        <description>SLE 15 SP1</description>
        <url>https://download.opensuse.org/repositories/SUSE:/SLE-15-SP1:/GA/pool/</url>
      </repository>
      <repository recommended="true">
        <name>SUSE:SLE-15:Update</name>
        <summary>SLE 15</summary>
        <description>SLE 15</description>
        <url>https://download.opensuse.org/distribution/leap/15.5/repo/oss/</url>
      </repository>
      <repository recommended="false">
        <name>SUSE:SLE-15:GA</name>
        <summary>SLE 15</summary>
        <description>SLE 15</description>
        <url>https://download.opensuse.org/repositories/SUSE:/SLE-15:/GA/pool/</url>
      </repository>
    </repositories>
    <software>
      <item>
        <name>R-pssmooth</name>
        <summary>Flexible and Efficient Evaluation of Principal Surrogates/Treatment Effect Modifiers</summary>
        <description>Implements estimation and testing procedures for evaluating an
intermediate biomarker response as a principal surrogate of a clinical
response to treatment (i.e., principal stratification effect
modification analysis), as described in Juraska M, Huang Y, and Gilbert
PB (2020), Inference on treatment effect modification by biomarker
response in a three-phase sampling design, Biostatistics, 21(3):
545-560 &lt;doi:10.1093/biostatistics/kxy074&gt;. The methods avoid the
restrictive 'placebo structural risk' modeling assumption common to
past methods and further improve robustness by the use of nonparametric
kernel smoothing for biomarker density estimation. A randomized
controlled two-group clinical efficacy trial is assumed with an ordered
categorical or continuous univariate biomarker response measured at a
fixed timepoint post-randomization and with a univariate baseline
surrogate measure allowed to be observed in only a subset of trial
participants with an observed biomarker response (see the flexible
three-phase sampling design in the paper for details). Bootstrap-based
procedures are available for pointwise and simultaneous confidence
intervals and testing of four relevant hypotheses. Summary and plotting
functions are provided for estimation results.</description>
      </item>
    </software>
  </group>
</metapackage>
